The mechanism, considered.
Weight is rarely about willpower. It is a downstream signal of insulin sensitivity, hormonal balance, sleep, stress, gut health and inflammatory load. ADARE's medical weight loss program treats it that way — as a metabolic problem with measurable inputs.
At the core of most protocols are prescription metabolic medications — including GLP-1 receptor agonists and dual-action GLP-1/GIP receptor agonists — which regulate appetite, slow gastric emptying and improve insulin sensitivity. These medications are compounded by licensed pharmacies, prescribed by our providers following individual clinical evaluation, and tailored to your specific metabolic profile. Compounded medications are not FDA-approved finished drug products. Used appropriately, they unlock progress that diet and willpower alone could not.
But medication is one layer. We pair it with comprehensive labs, body composition assessment, nutrition guidance, resistance-training direction and, when appropriate, hormone optimization, supportive peptides and metabolic injections.
This is not a prescription pad and a goodbye. It is a calibrated, monitored protocol with a real provider on the other end.
ADARE does not accept insurance. We accept HSA and FSA funds where eligible according to the details of your individual plan. Many clients find the investment worthwhile given the level of clinical oversight, personalized protocol design and provider access included in our program — which goes significantly beyond what is typically available through insurance-covered providers.
GLP-1 therapy for metabolic health, inflammation and longevity.
Not everyone who comes to ADARE for GLP-1 therapy is here to lose weight. A growing number of our clients are using these medications at lower, carefully calibrated doses for their broader metabolic and anti-inflammatory effects — as part of a comprehensive longevity protocol.
GLP-1 receptors are distributed across virtually every organ system — heart, brain, kidneys, liver — and activating them triggers a cascade of anti-inflammatory and cellular repair mechanisms that go far beyond appetite regulation. Clinical research has demonstrated meaningful reductions in cardiovascular risk, inflammatory markers and metabolic dysfunction — independent of weight loss.
At lower doses, GLP-1 therapy may support:
- Reduction in systemic inflammation
- Improved insulin sensitivity and metabolic regulation
- Cardiovascular health and blood pressure
- Neuroprotection and cognitive clarity
- Liver health and lipid optimization
- Overall metabolic resilience as part of a longevity protocol
This approach is particularly relevant for clients in their 30s, 40s and beyond who are not focused on weight loss but want to address chronic inflammation, optimize metabolic function, or add a powerful layer to their existing longevity protocol. It is also a consideration for perimenopausal and postmenopausal women navigating the metabolic shifts of this phase of life.
The research in this area is actively evolving. At ADARE, we stay current with the science and work with each client individually — evaluating whether lower-dose GLP-1 therapy makes sense for their specific biology, goals and health history. This is never a one-size-fits-all decision. It begins, as everything at ADARE does, with an honest conversation.
Lower-dose GLP-1 therapy for metabolic health and inflammation is an emerging area of medicine. While clinical evidence supports the broader systemic effects of GLP-1 receptor agonists, the research on specific microdosing protocols continues to evolve. All protocols at ADARE are prescribed following thorough individual clinical evaluation. Compounded medications are not FDA-approved finished drug products.
Curious whether this approach is right for you? Start with a conversation.
Book a ConsultationA protocol, not a procedure.
- 01
Personalized Consultation
An unhurried intake covers medical history, goals, prior weight history and barriers. We order comprehensive labs including metabolic, hormonal and inflammatory markers.
- 02
The Treatment
Once labs return, your provider prescribes the appropriate medication and dose, teaches you injection technique and sets clear weekly expectations. Nutrition and movement guidance is included from day one.
- 03
Aftercare & Follow Up
We check in regularly, titrate dose carefully to manage side effects, and reassess labs along the way. The goal is sustainable progress — and an exit strategy when the time comes.
What to Expect
Most clients lose between 1 and 2 percent of body weight per week in the early phase, with the rate slowing as the body recalibrates. Meaningful loss of 10 to 20 percent of body weight is common across a thoughtfully run protocol.
Equally important: improvements in fasting glucose, insulin sensitivity, blood pressure, sleep, joint pain and energy. We protect lean muscle through nutrition and training so the weight you lose is the right weight.
This is for you if…
- Adults with a BMI above 27 or significant metabolic dysfunction
- Clients who have tried diet and exercise alone without sustained results
- Perimenopausal or postmenopausal women navigating metabolic shift
- Anyone with insulin resistance, prediabetes or fatty liver concerns
This may not be right if…
- Personal or family history of medullary thyroid carcinoma or MEN2
- History of pancreatitis
- Pregnancy, breastfeeding or active fertility treatment without specialist input
- Severe gastroparesis or active eating disorder
- Active gallbladder disease without medical clearance
Every protocol begins with a comprehensive evaluation to ensure it aligns with your unique physiology and goals.
Layered care, by design.
Frequently Asked Questions
Ready to start a conversation?
Every protocol begins with listening. Come in for a consult — no pressure, no upsell.
Book a Consultation